AWS launches Amazon Bio Discovery to put lab-in-the-loop drug design on cruise control
AWS just rolled out Amazon Bio Discovery, a no-code agentic platform that puts 40+ biological AI models and wet-lab validation under one roof. Instead of juggling custom pipelines and manual handoffs, teams can pick models via AI agents, order lab assays from partners like Ginkgo Bioworks, and feed results right back into the loop. In tests with MSK, it sifted 300,000 antibody candidates in weeks instead of a full year.